Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial

Luigi Di Biase; Prasant Mohanty; Sanghamitra Mohanty; Pasquale Santangeli; Chintan Trivedi; Dhanunjaya Lakkireddy; Madhu Reddy; Pierre Jais; Sakis Themistoclakis; Antonio Dello Russo; Michela Casella; Gemma Pelargonio; Maria Lucia Narducci; Robert Schweikert; Petr Neuzil; Javier Sanchez; Rodney Horton; Salwa Beheiry; Richard Hongo; Steven Hao; Antonio Rossillo; Giovanni Forleo; Claudio Tondo; J. David Burkhardt; Michel Haissaguerre; Andrea Natale

doi:10.1161/CIRCULATIONAHA.115.019406

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial

Luigi Di Biase, Prasant Mohanty, Sanghamitra Mohanty, Pasquale Santangeli, Chintan Trivedi, Dhanunjaya Lakkireddy, Madhu Reddy, Pierre Jais, Sakis Themistoclakis, Antonio Dello Russo, Michela Casella, Gemma Pelargonio, Maria Lucia Narducci, Robert Schweikert, Petr Neuzil, Javier Sanchez, Rodney Horton, Salwa Beheiry, Richard Hongo, Steven HaoAntonio Rossillo, Giovanni Forleo, Claudio Tondo, J. David Burkhardt, Michel Haissaguerre, Andrea Natale

Centro Cardiologico Monzino

Research output: Contribution to journal › Article › peer-review

Abstract

Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction

Original language	English
Pages (from-to)	1637-1644
Number of pages	8
Journal	Circulation
Volume	133
Issue number	17
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.115.019406
Publication status	Published - Apr 26 2016

Keywords

amiodarone
atrial fibrillation
catheter ablation
heart failure

ASJC Scopus subject areas

Physiology (medical)
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/CIRCULATIONAHA.115.019406

Cite this

Di Biase, L., Mohanty, P., Mohanty, S., Santangeli, P., Trivedi, C., Lakkireddy, D., Reddy, M., Jais, P., Themistoclakis, S., Dello Russo, A., Casella, M., Pelargonio, G., Narducci, M. L., Schweikert, R., Neuzil, P., Sanchez, J., Horton, R., Beheiry, S., Hongo, R., ... Natale, A. (2016). Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation, 133(17), 1637-1644. https://doi.org/10.1161/CIRCULATIONAHA.115.019406

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device : Results From the AATAC Multicenter Randomized Trial. / Di Biase, Luigi; Mohanty, Prasant; Mohanty, Sanghamitra; Santangeli, Pasquale; Trivedi, Chintan; Lakkireddy, Dhanunjaya; Reddy, Madhu; Jais, Pierre; Themistoclakis, Sakis; Dello Russo, Antonio; Casella, Michela; Pelargonio, Gemma; Narducci, Maria Lucia; Schweikert, Robert; Neuzil, Petr; Sanchez, Javier; Horton, Rodney; Beheiry, Salwa; Hongo, Richard; Hao, Steven; Rossillo, Antonio; Forleo, Giovanni; Tondo, Claudio; Burkhardt, J. David; Haissaguerre, Michel; Natale, Andrea.

In: Circulation, Vol. 133, No. 17, 26.04.2016, p. 1637-1644.

Research output: Contribution to journal › Article › peer-review

Di Biase, L, Mohanty, P, Mohanty, S, Santangeli, P, Trivedi, C, Lakkireddy, D, Reddy, M, Jais, P, Themistoclakis, S, Dello Russo, A, Casella, M, Pelargonio, G, Narducci, ML, Schweikert, R, Neuzil, P, Sanchez, J, Horton, R, Beheiry, S, Hongo, R, Hao, S, Rossillo, A, Forleo, G, Tondo, C, Burkhardt, JD, Haissaguerre, M & Natale, A 2016, 'Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial', Circulation, vol. 133, no. 17, pp. 1637-1644. https://doi.org/10.1161/CIRCULATIONAHA.115.019406

Di Biase, Luigi ; Mohanty, Prasant ; Mohanty, Sanghamitra ; Santangeli, Pasquale ; Trivedi, Chintan ; Lakkireddy, Dhanunjaya ; Reddy, Madhu ; Jais, Pierre ; Themistoclakis, Sakis ; Dello Russo, Antonio ; Casella, Michela ; Pelargonio, Gemma ; Narducci, Maria Lucia ; Schweikert, Robert ; Neuzil, Petr ; Sanchez, Javier ; Horton, Rodney ; Beheiry, Salwa ; Hongo, Richard ; Hao, Steven ; Rossillo, Antonio ; Forleo, Giovanni ; Tondo, Claudio ; Burkhardt, J. David ; Haissaguerre, Michel ; Natale, Andrea. / Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device : Results From the AATAC Multicenter Randomized Trial. In: Circulation. 2016 ; Vol. 133, No. 17. pp. 1637-1644.

@article{d373d2b966804df5852875de7e9c9d6a,

title = "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial",

abstract = "Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction ",

keywords = "amiodarone, atrial fibrillation, catheter ablation, heart failure",

author = "{Di Biase}, Luigi and Prasant Mohanty and Sanghamitra Mohanty and Pasquale Santangeli and Chintan Trivedi and Dhanunjaya Lakkireddy and Madhu Reddy and Pierre Jais and Sakis Themistoclakis and {Dello Russo}, Antonio and Michela Casella and Gemma Pelargonio and Narducci, {Maria Lucia} and Robert Schweikert and Petr Neuzil and Javier Sanchez and Rodney Horton and Salwa Beheiry and Richard Hongo and Steven Hao and Antonio Rossillo and Giovanni Forleo and Claudio Tondo and Burkhardt, {J. David} and Michel Haissaguerre and Andrea Natale",

year = "2016",

month = apr,

day = "26",

doi = "10.1161/CIRCULATIONAHA.115.019406",

language = "English",

volume = "133",

pages = "1637--1644",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "17",

}

TY - JOUR

T1 - Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device

T2 - Results From the AATAC Multicenter Randomized Trial

AU - Di Biase, Luigi

AU - Mohanty, Prasant

AU - Mohanty, Sanghamitra

AU - Santangeli, Pasquale

AU - Trivedi, Chintan

AU - Lakkireddy, Dhanunjaya

AU - Reddy, Madhu

AU - Jais, Pierre

AU - Themistoclakis, Sakis

AU - Dello Russo, Antonio

AU - Casella, Michela

AU - Pelargonio, Gemma

AU - Narducci, Maria Lucia

AU - Schweikert, Robert

AU - Neuzil, Petr

AU - Sanchez, Javier

AU - Horton, Rodney

AU - Beheiry, Salwa

AU - Hongo, Richard

AU - Hao, Steven

AU - Rossillo, Antonio

AU - Forleo, Giovanni

AU - Tondo, Claudio

AU - Burkhardt, J. David

AU - Haissaguerre, Michel

AU - Natale, Andrea

PY - 2016/4/26

Y1 - 2016/4/26

N2 - Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction

AB - Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction

KW - amiodarone

KW - atrial fibrillation

KW - catheter ablation

KW - heart failure

UR - http://www.scopus.com/inward/record.url?scp=84962124333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962124333&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.115.019406

DO - 10.1161/CIRCULATIONAHA.115.019406

M3 - Article

AN - SCOPUS:84962124333

VL - 133

SP - 1637

EP - 1644

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 17

ER -

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this